Günther Bonn is taking on the additional position of ADSI CEO, Markus Pasterk is to become “Senior Advisor for International Relations”
Günther Bonn is taking on the additional position of ADSI CEO Markus Pasterk is to become “Senior Advisor for International Relations” The Austrian Drug Screening Institute (ADSI) in Innsbruck has decided to additionally bestow the position of Executive Director and CEO on its current Scientific Director, o.Univ.-Prof.Mag.Dr.Dr.h.c. Günther Bonn, during its 10th Annual General [...]
Plants play an important role in medicine, cosmetics and, of course, nutrition. The ADSI in Innsbruck - illustrated by the example of olive oil - is investigating what substances in which composition have health-promoting effects. Read article.
PreCanMed: cross-border cancer research from Tyrol to Friuli Venezia Giulia to promote personalised cancer medicine
The Italian-Austrian team of PreCanMed will meet today for the first PreCanMed Workshop in Innsbruck and present the perspectives of their research and innovation initiative in precision cancer medicine. In public lectures, the experts will also give students, researchers and interested citizens an insight into the latest findings of cancer research. Innsbruck, 30. May 2017 [...]
With the determination of the crystalline structure of the protein complex LAMTOR, scientists led by Lukas Huber also discovered the sensitive "Achilles' heel" of the complex and would like to use this knowledge to advance the development of new therapeutic approaches in the future. The protein complex LAMTOR was identified 15 years ago and, as [...]
The Michael-Popp-Foundation and the State of Tyrol initiated a new institute for herbal drug research at the University of Innsbruck. A further institute enriches the Tyrolean research landscape. The new Research Institute for New Phyto Entities will be established at the University of Innsbruck aiming to accelerate the scientific know-how in the field of new [...]